BioSpace News Archive

Business

BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update

BioNTech SE reported financial results for the three and nine months ended September 30, 2022 and provided an update on its corporate progress.

November 7, 2022
·
40 min read
Business

Protalix BioTherapeutics to Report Third Quarter 2022 Financial and Business Results on November 14, 2022

Protalix BioTherapeutics, Inc. today announced that it will release its financial results for the third quarter 2022 and provide a business update on Monday, November 14, 2022.

November 7, 2022
·
3 min read
Business

Eagle Pharmaceuticals Reports Third Quarter 2022 Results

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and nine months ended September 30, 2022.

November 7, 2022
·
38 min read
Genetown

Orchard Therapeutics to Webcast Conference Call of Third Quarter 2022 Financial Results

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will host a conference call and live webcast on Monday, November 14, 2022, at 8:00 a.m. EST to review business updates and its third quarter 2022 financial results.

November 7, 2022
·
2 min read
Business

Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the third quarter ended September 30, 2022.

November 7, 2022
·
15 min read
Business

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates

Amicus Therapeutics today announced financial results for the quarter ended September 30, 2022.

November 7, 2022
·
20 min read
Genetown

Relay Therapeutics to Participate in Two Upcoming November 2022 Investor Conferences

Relay Therapeutics, Inc. is scheduled to participate in two fireside chats this month at the H.C. Wainwright 3rd Annual Precision Oncology Virtual Conference on Monday, November 14, 2022 at 10:00 a.m. ET and the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 1:15 p.m. ET.

November 7, 2022
·
1 min read
Asep Inc. is Granted Patent Approval for its Sepsis Diagnostic Technology in 13 European Countries and Australia

Asep Medical Holdings Inc. is very pleased to announce that the Company’s sepsis diagnostic technology, called Sepset ER TM, has received successful patent approval in 13 European countries as well as in Australia.

November 7, 2022
·
5 min read
Drug Development

F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

F-star Therapeutics, Inc. today announced the publication of safety and efficacy results from Phase 1 trial of FS118 in patients with advanced cancer and PD-L1 resistance in Clinical Cancer Research, a journal of the American Association for Cancer Research.

November 7, 2022
·
8 min read
Business

Avalo Reports Third Quarter 2022 Financial Results and Provides Business Updates

Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the third quarter of 2022.

November 7, 2022
·
13 min read